Technical Considerations for Oncologic Colectomy

Abstract

Colectomy for malignant tumors or unresectable benign tumors requires preoperative planning based on cross-sectional imaging, consideration of neoadjuvant therapy, a decision on the extent of lymphadenectomy, and comprehensive knowledge of the relevant anatomy. Imaging review is critical for determining resectability and noting any aberrant anatomy. Based on the imaging, neoadjuvant therapy should be considered for bulky or locally advanced disease. The anatomical resection of the colon, mesentery, and lymph node basins is performed in accordance with the concept of complete mesocolic excision (CME), entailing the resection of the mesentery with visceral peritoneum intact, appropriate proximal and distal margins taken en bloc, and high ligation of the primary feeding vessels along which the lymph nodes are positioned. High ligation of the colic arteries is part of a standard lymphadenectomy and is intended to address possible micrometastatic nodal disease and proper staging for adjuvant therapy. Extended lymphadenectomy in the form of CME with central vascular ligation is indicated for patients with advanced T stage or clinical lymphadenopathy. Whether extended lymphadenectomy should be performed routinely is subject to debate. In this article, we review the indications and operative strategies for management of colon cancer in various locations in the colon, as well as key considerations for minimally invasive colectomy and advanced techniques such as CME with central vascular ligation.

Keywords

colectomy - colon cancer - complete mesocolic excision

Publikationsverlauf

Artikel online veröffentlicht:
15. Januar 2025

• References

• 1 Kasi PM, Aushev VN, Ensor J. et al. Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study. J Clin Oncol 2024; 42 (03) 9
• 2 Kotani D, Oki E, Nakamura Y. et al. Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer. Nat Med 2023; 29 (01) 127-134
• 3 National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 5.2024. August 2024 Accessed September 1, 2024 at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1428
• 4 Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis 2009; 11 (04) 354-364 , discussion 364–365
• 5 Hashiguchi Y, Muro K, Saito Y. et al; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 2020; 25 (01) 1-42
• 6 Vogel JD, Felder SI, Bhama AR. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer. Dis Colon Rectum 2022; 65 (02) 148-177
• 7 Bertelsen CA, Neuenschwander AU, Jansen JE. et al. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study. Lancet Oncol 2019; 20 (11) 1556-1565
• 8 Kotake K, Mizuguchi T, Moritani K. et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis 2014; 29 (07) 847-852
• 9 Mazzarella G, Muttillo EM, Picardi B, Rossi S, Muttillo IA. Complete mesocolic excision and D3 lymphadenectomy with central vascular ligation in right-sided colon cancer: a systematic review of postoperative outcomes, tumor recurrence and overall survival. Surg Endosc 2021; 35 (09) 4945-4955
• 10 Lu J, Xing J, Zang L. et al; RELARC study group. Extent of lymphadenectomy for surgical management of right-sided colon cancer: the randomized phase III RELARC trial. J Clin Oncol 2024; 42 (33) 3957-3966
• 11 Xu L, Su X, He Z. et al; RELARC Study Group. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol 2021; 22 (03) 391-401
• 12 Karachun A, Panaiotti L, Chernikovskiy I. et al. Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial). Br J Surg 2020; 107 (05) 499-508
• 13 Russian Society of Colorectal Surgeons. D2 vs D3 Lymph Node Dissection for Left Colon Cancer (DILEMMA). Bethesda, MD: ClinicalTrials.gov;
• 14 Hashiguchi Y, Hase K, Ueno H, Mochizuki H, Shinto E, Yamamoto J. Optimal margins and lymphadenectomy in colonic cancer surgery. Br J Surg 2011; 98 (08) 1171-1178
• 15 Nelson H, Petrelli N, Carlin A. et al; National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93 (08) 583-596
• 16 Rørvig S, Schlesinger N, Mårtensson NL, Engel S, Engel U, Holck S. Is the longitudinal margin of carcinoma-bearing colon resections a neglected parameter?. Clin Colorectal Cancer 2014; 13 (01) 68-72
• 17 Widmar M, Aggarwal P, Keskin M. et al. Intracorporeal anastomoses in minimally invasive right colectomies are associated with fewer incisional hernias and shorter length of stay. Dis Colon Rectum 2020; 63 (05) 685-692
• 18 den Hartog FPJ, van Egmond S, Poelman MM. et al. The incidence of extraction site incisional hernia after minimally invasive colorectal surgery: a systematic review and meta-analysis. Colorectal Dis 2023; 25 (04) 586-599
• 19 Cleary RK, Silviera M, Reidy TJ. et al. Intracorporeal and extracorporeal anastomosis for robotic-assisted and laparoscopic right colectomy: short-term outcomes of a multi-center prospective trial. Surg Endosc 2022; 36 (06) 4349-4358
• 20 Steffen C, Bokey EL, Chapuis PH. Carcinoma of the splenic flexure. Dis Colon Rectum 1987; 30 (11) 872-874
• 21 Skinner D, Wehrle CJ, Van Fossen K. Anatomy, Abdomen and Pelvis: Inferior Mesenteric Artery. Treasure Island, FL: StatPearls Publishing; 2021
• 22 Gourley EJ, Gering SA. The meandering mesenteric artery: a historic review and surgical implications. Dis Colon Rectum 2005; 48 (05) 996-1000
• 23 Murono K, Nozawa H, Kawai K. et al. Vascular anatomy of the splenic flexure: a review of the literature. Surg Today 2022; 52 (05) 727-735
• 24 Miyake H, Murono K, Kawai K. et al. Evaluation of the vascular anatomy of the left-sided colon focused on the accessory middle colic artery: a single-centre study of 734 patients. Colorectal Dis 2018; 20 (11) 1041-1046
• 25 Slieker JC, Daams F, Mulder IM, Jeekel J, Lange JF. Systematic review of the technique of colorectal anastomosis. JAMA Surg 2013; 148 (02) 190-201
• 26 Martínez-Pérez A, Brunetti F, Vitali GC, Abdalla S, Ris F, de'Angelis N. Surgical treatment of colon cancer of the splenic flexure: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech 2017; 27 (05) 318-327
• 27 Degiuli M, Reddavid R, Ricceri F. et al; and Members of the Italian Society of Surgical Oncology Colorectal Cancer Network (SICO-CCN) Collaborative Group [A listing of all authors appears at the end of the article]. Segmental colonic resection is a safe and effective treatment option for colon cancer of the splenic flexure: a nationwide retrospective study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group. Dis Colon Rectum 2020; 63 (10) 1372-1382
• 28 Manceau G, Mori A, Bardier A. et al. Lymph node metastases in splenic flexure colon cancer: Is subtotal colectomy warranted?. J Surg Oncol 2018; 118 (06) 1027-1033
• 29 Toh JWT, Matthews R, Kim SH. Arc of Riolan-preserving splenic flexure takedown during anterior resection: potentially critical to prevent acute anastomotic ischemia. Dis Colon Rectum 2018; 61 (03) 411-414